Grifols (GRFS) Receivables - Other (2009 - 2025)

Grifols (GRFS) posted Receivables - Other of $117.6 million for Q4 2025, up 41.05% quarter-over-quarter from $83.4 million in Q4 2024, and up 41.05% year-on-year from $83.4 million in Q4 2024.

Grifols (GRFS) Receivables - Other (2009 - 2025) Analysis & Trends

Grifols (GRFS) has reported Receivables - Other for 16 consecutive years, with $117.6 million the latest figure, recorded in Q4 2025.

  • Receivables - Other for Q4 2025 came in at $117.6 million, up 41.05% year-over-year; the trailing twelve-month figure through Dec 2025 was $117.6 million (up 41.05% YoY), and the FY2025 annual result was $117.6 million, up 41.05% from the prior year.
  • Receivables - Other was $117.6 million for Q4 2025 at Grifols, up from $83.4 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $150.7 million in Q4 2021 and troughed at $74.7 million in Q4 2022.
  • Average Receivables - Other over 5 years is $101.4 million, with a median of $83.4 million recorded in 2024.
  • Year-over-year, Receivables - Other surged 74.72% in 2021 and sank 50.47% in 2022.
  • Over 5 years, Receivables - Other stood at $150.7 million in 2021, then tumbled by 50.47% to $74.7 million in 2022, then climbed by 7.98% to $80.6 million in 2023, then advanced by 3.38% to $83.4 million in 2024, then jumped by 41.05% to $117.6 million in 2025.
  • Per Business Quant data, the three most recent Receivables - Other figures were $117.6 million in Q4 2025, $83.4 million in Q4 2024, and $80.6 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 117.57 Mn
Dec 31, 2025 117.57 Mn
Dec 31, 2024 83.35 Mn
Dec 31, 2024 83.35 Mn
Dec 31, 2023 245.28 Mn
Dec 31, 2023 245.28 Mn
Dec 31, 2022 74.66 Mn
Dec 31, 2022 74.66 Mn
Dec 31, 2021 150.73 Mn
Dec 31, 2021 150.73 Mn
Dec 31, 2020 86.27 Mn
Dec 31, 2020 86.27 Mn
Dec 31, 2019 91.33 Mn
Dec 31, 2019 91.33 Mn
Dec 31, 2018 105.49 Mn
Dec 31, 2018 105.49 Mn
Jun 30, 2018 14.23 Mn
Jun 30, 2018 14.23 Mn
Dec 31, 2017 47.90 Mn
Dec 31, 2017 47.90 Mn